Hayley Evans: Variability in Perioperative TXA Practice Despite Strong Evidence
Hayley Evans, Deputy Director at the NIHR Blood and Transplant Research Unit in Data Driven Transfusion Practice, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in BJHaem, adding:
“One of the interesting areas of perioperative research is not simply what works, but why evidence based practice is adopted inconsistently in real world clinical settings.
Our new paper in the British Journal of Haematology explores this through perioperative tranexamic acid (TXA) use across UK surgical practice.
Despite strong evidence supporting TXA, clinicians still vary considerably in how and when they use it.
Using a behavioural science framework, we explored some of the cognitive, cultural and organisational factors behind that variation.
Implementation is rarely just about evidence alone.”
Title: Survey on perioperative tranexamic acid use
Authors: Louise H. Strickland, Hayley G. Evans, Olivia C. Robinson, Samantha Warnakulasuriya, Robbie Foy, Simon J. Stanworth
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke